SEC Form 4 · accession 0001179110-18-009559

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP - Business Development

Period of report

Jul 3, 2018

Accepted (ET)

Jul 9, 2018 · 4:11 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jul 3, 2018	M	8,202	$6.01	A	9,378	D
Common Stock	Jul 3, 2018	M	2,841	$12.21	A	12,219	D
Common Stock	Jul 3, 2018	M	2,778	$22.30	A	14,997	D
Common Stock^F5	Jul 3, 2018	S	13,821	$59.43	D	1,176	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$6.01	Jul 3, 2018	M	8,202	D	—	Dec 18, 2024	Common Stock	8,202	19,138	D
Employee Stock Option (right to buy)^F2	$12.21	Jul 3, 2018	M	2,841	D	—	Mar 7, 2026	Common Stock	2,841	20,831	D
Employee Stock Option (right to buy)^F3	$22.30	Jul 3, 2018	M	2,778	D	—	Mar 3, 2027	Common Stock	2,778	47,229	D

F1The option vests as to 25% of the shares on December 18, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
F2The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
F3The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
F4The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018.
F5Represents the weighted average price of transactions ranging from $59.30 to $59.50. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.